Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Ultra wide-field lens-free monitoring of cells on-chip.

Ozcan A, Demirci U.

Lab Chip. 2008 Jan;8(1):98-106. Epub 2007 Nov 1.

PMID:
18094767
2.

Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resource-limited settings.

Pattanapanyasat K, Phuang-Ngern Y, Sukapirom K, Lerdwana S, Thepthai C, Tassaneetrithep B.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):339-47.

PMID:
19186347
3.

High-throughput lensfree imaging and characterization of a heterogeneous cell solution on a chip.

Su TW, Seo S, Erlinger A, Ozcan A.

Biotechnol Bioeng. 2009 Feb 15;102(3):856-868. doi: 10.1002/bit.22116.

4.

On-chip magnetic bead microarray using hydrodynamic focusing in a passive magnetic separator.

Smistrup K, Kjeldsen BG, Reimers JL, Dufva M, Petersen J, Hansen MF.

Lab Chip. 2005 Nov;5(11):1315-9. Epub 2005 Oct 4.

PMID:
16234958
5.

Lensless on-chip imaging of cells provides a new tool for high-throughput cell-biology and medical diagnostics.

Mudanyali O, Erlinger A, Seo S, Su TW, Tseng D, Ozcan A.

J Vis Exp. 2009 Dec 14;(34). pii: 1650. doi: 10.3791/1650.

6.

CD4 and CD8 enumeration for HIV monitoring in resource-constrained settings.

Li X, Breukers C, Ymeti A, Lunter B, Terstappen LW, Greve J.

Cytometry B Clin Cytom. 2009 Mar;76(2):118-26. doi: 10.1002/cyto.b.20445.

7.

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy.

Moore DM, Awor A, Downing R, Kaplan J, Montaner JS, Hancock J, Were W, Mermin J.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):477-84. doi: 10.1097/QAI.0b013e318186eb18.

PMID:
18989232
8.
9.

CD4+ T-lymphocyte enumeration with a flow-rate based method in three flow cytometers with different years in service.

Pattanapanyasat K, Chimma P, Sratongno P, Lerdwana S.

Cytometry B Clin Cytom. 2008 Sep;74(5):310-8. doi: 10.1002/cyto.b.20425.

10.

Integrating microfluidics and lensless imaging for point-of-care testing.

Moon S, Keles HO, Ozcan A, Khademhosseini A, Haeggstrom E, Kuritzkes D, Demirci U.

Biosens Bioelectron. 2009 Jul 15;24(11):3208-14. doi: 10.1016/j.bios.2009.03.037. Epub 2009 Apr 2.

11.

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study.

Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Erratum in: Clin Infect Dis. 2009 May 15;48(10):1491.

PMID:
18783328
12.

Tissue array substratum composed of histological sections: a new platform for orienting differentiation of embryonic stem cells towards hepatic lineage.

Takeuchi T, Ochiya T, Takezawa T.

Tissue Eng Part A. 2008 Feb;14(2):267-74. doi: 10.1089/tea.2007.0188.

PMID:
18333779
13.

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.

Guiguet M, Kendjo E, Carcelain G, Abgrall S, Mary-Krause M, Tattevin P, Yazdanpanah Y, Costagliola D, Duval X; FHDH-ANRS CO4 Epidemiology Group.

Antivir Ther. 2009;14(3):451-7.

PMID:
19474479
14.

CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.

O'Gorman MR, Zijenah LS.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S19-26. doi: 10.1002/cyto.b.20398. Review.

15.

Rapid, low-cost and instrument-free CD4+ cell counting for HIV diagnostics in resource-poor settings.

Glynn MT, Kinahan DJ, Ducrée J.

Lab Chip. 2014 Aug 7;14(15):2844-51. doi: 10.1039/c4lc00264d. Epub 2014 Jun 9.

PMID:
24911165
16.

Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count.

Lichtner M, Rossi R, Rizza MC, Mengoni F, Sauzullo I, Massetti AP, Luzi G, Hosmalin A, Mastroianni CM, Vullo V.

Curr HIV Res. 2008 Jan;6(1):19-27.

PMID:
18288971
17.

From research tool to routine test: CD38 monitoring in HIV patients.

Coetzee LM, Tay SS, Lawrie D, Janossy G, Glencross DK.

Cytometry B Clin Cytom. 2009 Nov;76(6):375-84. doi: 10.1002/cyto.b.20478.

18.

New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients.

Pattanapanyasat K, Sukapirom K, Kowawisatsut L, Thepthai C.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S98-106. doi: 10.1002/cyto.b.20415.

19.

Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings.

Kiertiburanakul S, Sungkanuparph S, Charoenyingwattana A, Mahasirimongkol S, Sura T, Chantratita W.

Curr HIV Res. 2008 Jan;6(1):65-9.

PMID:
18288977
20.

CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.

Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S131-40. doi: 10.1002/cyto.b.20391.

Supplemental Content

Support Center